Regulation of tyrosine hydroxylase after chronic treatment with classic and atypical antischizophrenic drugs.
D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001921:Brain / Q000201:enzymology*; D003024:Clozapine / Q000494:pharmacology; D003342:Corpus Striatum / Q000201:enzymology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D009714:Nucleus Accumbens / Q000201:enzymology; D051381:Rats; D013469:Sulpiride / Q000494:pharmacology; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D014150:Antipsychotic Agents; D013469:Sulpiride; D014446:Tyrosine 3-Monooxygenase; D003024:Clozapine; D006220:Haloperidol